The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.smaller Cos. Regulatory News (BSV)

Share Price Information for Br.smaller Cos. (BSV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 80.00
Bid: 78.50
Ask: 81.50
Change: 0.00 (0.00%)
Spread: 3.00 (3.822%)
Open: 80.00
High: 80.00
Low: 80.00
Prev. Close: 80.00
BSV Live PriceLast checked at -
British Smaller Companies VCT is an Investment Trust

To maximise Total Return and provide investors with an attractive long-term tax-free dividend yield while maintaining the Company's status as a venture capital trust.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

23 Feb 2018 09:06

RNS Number : 7741F
British Smaller Companies VCT PLC
23 February 2018
 

 

British Smaller Companies VCT plc

Interim Management Statement

For the quarter ended 31 December 2017

British Smaller Companies VCT plc (the "Company") presents its interim management statement for the quarter ended 31 December 2017. The statement also includes relevant financial information between the end of the quarter and the date of this statement. A copy of this interim management statement can be found at www.bscfunds.com.

Overview

The Company has continued to make good progress with total return rising to 214.8 pence per ordinary share; Net Asset Value ("NAV") stood at 78.4 pence per ordinary share. This is an increase of 1.4 pence per ordinary share in the quarter equivalent to 1.8% growth in the period.

Performance

31 December 2017

Movement

30 September 2017

Net Assets (£m)

85.1

1.1

84.0

NAV per share (PPS)

78.4p

1.4p

77.0p

Cumulative dividends paid (PPS)

136.4p

-

136.4p

Total Return (PPS)

214.8p

1.4p

213.4p

Shares in issue

108,607,183

(500,000)

109,107,183

 

The total return at 31 December 2017, calculated by reference to the NAV per ordinary share and the cumulative dividends paid per ordinary share, was 214.8 pence per ordinary share compared to 213.4 pence per ordinary share at 30 September 2017.

The unaudited NAV per ordinary share as at 31 December 2017 was 78.4p pence per ordinary share (30 September 2017: 77.0 pence per ordinary share). Cumulative dividends paid were unchanged at 136.4 pence per ordinary share (30 September 2017: 136.4 pence per ordinary share).

Shares in issue

On 19 December 2017 the Company purchased 500,000 ordinary shares of 10 pence each at a price of 73.65 pence per ordinary share. These shares were placed in treasury.

The number of ordinary shares in issue at 31 December 2017 was 108,607,183 (30 September 2017: 109,107,183). In addition, at 31 December 2017 the Company held 4,807,999 ordinary shares in treasury (30 September 2017: 4,307,999).

Net assets

Net assets at 31 December 2017 comprised the following:

£000

% of net assets

Unquoted investments at fair value

54,459

64.0

Quoted investments at bid price

2,205

2.6

Total investments

56,664

66.6

Fixed income government securities

708

0.8

Quoted funds

1,893

2.2

Cash and cash equivalents

24,378

28.6

Other net current assets

1,477

1.8

Net assets

85,120

100.0

 

The investment portfolio at 31 December 2017 was comprised as follows:

Valuation

£000

Valuation as a % of net assets

Intelligent Office

 4,960

5.8

ACC Aviation

 4,672

5.5

Mangar Health Limited

 3,962

4.7

GTK (Holdco) Limited

 2,964

3.5

Springboard Research Holdings Limited

 2,896

3.4

Matillion Limited

2,728

3.2

Business Collaborator Limited

 2,703

3.2

Gill Marine Holdings Limited

 2,569

3.0

Deep-Secure Limited

 2,550

3.0

KeTech Enterprises Limited

2,336

2.7

32,340

38.0

Other investments

24,324

28.6

Total investments

56,664

66.6

 

There were no investments during the period.

In the quarter to 31 December 2017 the realisation and repayment of investments generated proceeds of £1.4 million.

 

Portfolio Performance

Over the quarter to 31 December 2017 aggregate unrealised portfolio valuations have increased by £1.6 million. There were strong performances in the quarter from the investments in GTK, Matillion, Deep-Secure and Business Collaborator, offset by reductions from RMS, Sipsynergy and DisplayPlan.

The Board continues to follow its policy of maintaining a diversified portfolio. At 31 December 2017, only two investments represented more than 5 per cent of the Company's NAV.

Outlook

Your Board remains encouraged by the increase in investment opportunities that it is seeing, although the conversion of this pipeline to new investments continues to be hampered by the slow granting of advance assurance from HMRC. The Company has just received advance assurances for two new investments (£3.3 million) which it is hoped will complete in the near future, and is awaiting assurance on one further investment of £1.3 million.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

 

 

23 February 2018

 

For further information please contact:

David Hall YFM Private Equity Limited Tel: 0113 244 1000

Jonathan Becher Panmure Gordon (UK) Limited Tel: 0207 886 2715

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
QRTPGUCUPUPRUBW
Date   Source Headline
4th Nov 20228:30 amRNSDividend Declaration
24th Oct 20229:00 amRNSChange of Registrar
3rd Oct 20221:30 pmRNSOffer Update
3rd Oct 20221:30 pmRNSOffer Update
3rd Oct 202212:25 pmRNSDirector/PDMR Shareholding
3rd Oct 202212:20 pmRNSPayment of Dividend and Issue of Equity
28th Sep 202211:13 amRNSTransaction in Own Shares
20th Sep 20229:30 amRNS1st Quarter Results
16th Sep 202211:42 amRNSResult of AGM
4th Aug 202211:45 amRNSDividend Declaration
2nd Aug 20221:15 pmRNSStatement re intention to fundraise
2nd Aug 20221:15 pmRNSStatement re intention to fundraise
12th Jul 202211:30 amRNSDirector/PDMR Shareholding
12th Jul 202211:30 amRNSDirector/PDMR Shareholding
12th Jul 202211:30 amRNSPayment of Dividend and Allotment of Shares
29th Jun 202210:00 amRNSPurchase of Own Securities and Net Asset Value
21st Jun 20223:00 pmRNSAnnual Financial Report
6th Jun 20227:58 amRNSDirectorate Change
31st May 20227:00 amRNSDividend Declaration
5th Apr 20228:33 amRNSDirector Declaration
30th Mar 20227:56 amRNSTransaction in Own Shares
21st Mar 20221:15 pmRNS3rd Quarter Results
1st Mar 20228:18 amRNSDirector Declaration
1st Feb 20228:30 amRNSDirector Declaration
7th Jan 202211:15 amRNSDirector/PDMR Shareholding
7th Jan 202211:15 amRNSDirector/PDMR Shareholding
7th Jan 202211:15 amRNSIssue of Equity and Close of Offers
5th Jan 202210:21 amRNSDirector/PDMR Shareholding
5th Jan 202210:20 amRNSPayment of interim dividend and issue of shares
16th Dec 20219:55 amRNSTransaction in Own Shares
6th Dec 202110:37 amRNSPublication of Supplementary Prospectus
6th Dec 202110:33 amRNSPublication of Supplementary Prospectus
18th Nov 20218:08 amRNSHalf-year Report
16th Nov 202110:08 amRNSDirector/PDMR Shareholding
16th Nov 202110:08 amRNSPayment of dividend and allotment of shares
12th Nov 20217:00 amRNSClose of Offers to New Applications
12th Nov 20217:00 amRNSClose of Offers to New Applications
11th Oct 20217:51 amRNSOffer Update
11th Oct 20217:49 amRNSOffer Update
7th Oct 20212:30 pmRNSInterim Dividend
28th Sep 20217:00 amRNSTransaction in Own Shares
27th Sep 20211:11 pmRNSOffer Update
27th Sep 20211:10 pmRNSOffer Update
24th Sep 202112:58 pmRNSOffer Update
24th Sep 202112:57 pmRNSOffer Update
22nd Sep 202112:00 pmRNSPublication of a Prospectus
22nd Sep 202112:00 pmRNSPublication of a Prospectus
10th Sep 20213:24 pmRNS1st Quarter Results
10th Sep 20212:06 pmRNSResult of AGM
27th Aug 20213:15 pmRNSStatement re Net Asset Value and Fundraising

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.